1. Noroozi, M., Mirzazadeh, A., Noroozi, A., Mehrabi, Y., Hajebi, A., Zamani, S., … & Soori, H. (2015). Client-level coverage of needle and syringe program and high-risk injection behaviors: a case study of people who inject drugs in Kermanshah, Iran. Addiction & health, 7(3-4), 164.

2. Sharifi, H., Akbarein, H., Akhondzadeh, S., Amirkhani, M., Asadi-Lari, M., AYATOLLAHI, M., … & Malekzadeh, R. (2015). Establishment of the National Network of WHO Collaborating Centres in Iran to Contribute to the National Public Health Needs. Archives of Iranian medicine, 18(8), 558-559.

3. Moradi, G., Farnia, M., Shokoohi, M., Shahbazi, M., Moazen, B., & Rahmani, K. (2015). Methadone maintenance treatment program in prisons from the perspective of medical and non-medical prison staff: a qualitative study in Iran. International journal of health policy and management, 4(9), 583.

4. Najafipour, H., Masoomi, M., Shahesmaeili, A., Haghdoost, A. A., Afshari, M., Nasri, H. R., … & Mirzazadeh, A. (2015). Effects of opium consumption on coronary artery disease risk factors and oral health: Results of Kerman Coronary Artery Disease Risk factors Study a population-based survey on 5900 subjects aged 15-75 years. International journal of preventive medicine.

5. Karamouzian, M., & Haghdoost, A. A. (2015). Population control policies in Iran. The Lancet, 385(9973), 1071

6. Karamouzian, M., Akbari, M., Haghdoost, A. A., Setayesh, H., & Zolala, F. (2015). “I am dead to them”: HIV-related stigma experienced by people living with HIV in Kerman, Iran. Journal of the Association of Nurses in AIDS Care, 26(1), 46-56.

7. Shahesmaeili, A., Haghdoost, A. A., & Soori, H. (2015). Network location and risk of human immunodeficiency virus transmission among injecting drug users: results of multiple membership multilevel modeling of social networks. Addiction & health, 7(1-2), 1.

8. Haghdoost, A. A., Baneshi, M. R., Haji-Maghsoodi, S., Molavi-Vardanjani, H., & Mohebbi, E. (2015). Application of a network scale-up method to estimate the size of population of breast, ovarian/cervical, prostate and bladder cancers. Asian Pac J Cancer Prev, 16, 3273.